キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/06/19 | 1,361 | 1,369 | 1,340 | 1,348 | -32 | -2.3% | 340,900 |
| 2023/06/16 | 1,381 | 1,401 | 1,367 | 1,380 | +1 | +0.1% | 267,400 |
| 2023/06/15 | 1,373 | 1,405 | 1,365 | 1,379 | -5 | -0.4% | 281,400 |
| 2023/06/14 | 1,430 | 1,430 | 1,384 | 1,384 | -50 | -3.5% | 356,600 |
| 2023/06/13 | 1,460 | 1,477 | 1,430 | 1,434 | -56 | -3.8% | 663,500 |
| 2023/06/12 | 1,377 | 1,656 | 1,350 | 1,490 | +112 | +8.1% | 1,979,300 |
| 2023/06/09 | 1,360 | 1,390 | 1,338 | 1,378 | +42 | +3.1% | 476,900 |
| 2023/06/08 | 1,393 | 1,394 | 1,330 | 1,336 | -56 | -4% | 485,500 |
| 2023/06/07 | 1,400 | 1,480 | 1,375 | 1,392 | +103 | +8% | 2,158,700 |
| 2023/06/06 | 1,339 | 1,346 | 1,281 | 1,289 | -50 | -3.7% | 399,200 |
| 2023/06/05 | 1,355 | 1,362 | 1,335 | 1,339 | -15 | -1.1% | 219,800 |
| 2023/06/02 | 1,351 | 1,355 | 1,333 | 1,354 | -4 | -0.3% | 220,000 |
| 2023/06/01 | 1,359 | 1,375 | 1,331 | 1,358 | +5 | +0.4% | 259,000 |
| 2023/05/31 | 1,396 | 1,398 | 1,352 | 1,353 | -43 | -3.1% | 231,500 |
| 2023/05/30 | 1,391 | 1,406 | 1,362 | 1,396 | +4 | +0.3% | 262,700 |
| 2023/05/29 | 1,353 | 1,427 | 1,336 | 1,392 | +40 | +3% | 471,100 |
| 2023/05/26 | 1,351 | 1,383 | 1,338 | 1,352 | -24 | -1.7% | 328,000 |
| 2023/05/25 | 1,382 | 1,398 | 1,340 | 1,376 | -24 | -1.7% | 557,200 |
| 2023/05/24 | 1,411 | 1,450 | 1,395 | 1,400 | -36 | -2.5% | 555,200 |
| 2023/05/23 | 1,494 | 1,512 | 1,425 | 1,436 | -71 | -4.7% | 563,100 |
| 2023/05/22 | 1,543 | 1,548 | 1,500 | 1,507 | -29 | -1.9% | 310,800 |
| 2023/05/19 | 1,457 | 1,600 | 1,445 | 1,536 | -71 | -4.4% | 1,512,100 |
| 2023/05/18 | 1,623 | 1,635 | 1,592 | 1,607 | -12 | -0.7% | 303,900 |
| 2023/05/17 | 1,621 | 1,629 | 1,596 | 1,619 | +12 | +0.7% | 248,500 |
| 2023/05/16 | 1,631 | 1,642 | 1,572 | 1,607 | -48 | -2.9% | 405,300 |
| 2023/05/15 | 1,551 | 1,666 | 1,538 | 1,655 | +81 | +5.1% | 472,700 |
| 2023/05/12 | 1,565 | 1,584 | 1,546 | 1,574 | +11 | +0.7% | 224,800 |
| 2023/05/11 | 1,596 | 1,596 | 1,540 | 1,563 | -35 | -2.2% | 307,200 |
| 2023/05/10 | 1,622 | 1,627 | 1,593 | 1,598 | -19 | -1.2% | 239,000 |
| 2023/05/09 | 1,605 | 1,650 | 1,601 | 1,617 | +13 | +0.8% | 390,300 |
| 2023/05/08 | 1,538 | 1,620 | 1,531 | 1,604 | +36 | +2.3% | 441,500 |
| 2023/05/02 | 1,590 | 1,594 | 1,540 | 1,568 | -32 | -2% | 543,700 |
| 2023/05/01 | 1,611 | 1,628 | 1,587 | 1,600 | -43 | -2.6% | 464,300 |
| 2023/04/28 | 1,609 | 1,664 | 1,601 | 1,643 | +39 | +2.4% | 575,300 |
| 2023/04/27 | 1,589 | 1,613 | 1,543 | 1,604 | +11 | +0.7% | 499,300 |
| 2023/04/26 | 1,698 | 1,698 | 1,590 | 1,593 | -93 | -5.5% | 781,100 |
| 2023/04/25 | 1,734 | 1,741 | 1,653 | 1,686 | -50 | -2.9% | 817,700 |
| 2023/04/24 | 1,816 | 1,828 | 1,735 | 1,736 | -94 | -5.1% | 871,900 |
| 2023/04/21 | 1,795 | 1,871 | 1,757 | 1,830 | +58 | +3.3% | 1,634,300 |
| 2023/04/20 | 1,710 | 1,815 | 1,685 | 1,772 | +31 | +1.8% | 1,171,000 |
| 2023/04/19 | 1,810 | 1,859 | 1,703 | 1,741 | -104 | -5.6% | 1,616,600 |
| 2023/04/18 | 1,858 | 1,950 | 1,792 | 1,845 | +247 | +15.5% | 4,900,300 |
| 2023/04/17 | 1,670 | 1,678 | 1,581 | 1,598 | -72 | -4.3% | 759,900 |
| 2023/04/14 | 1,681 | 1,709 | 1,642 | 1,670 | -8 | -0.5% | 1,135,400 |
| 2023/04/13 | 1,582 | 1,688 | 1,555 | 1,678 | +92 | +5.8% | 1,099,700 |
| 2023/04/12 | 1,565 | 1,607 | 1,525 | 1,586 | +22 | +1.4% | 924,400 |
| 2023/04/11 | 1,500 | 1,575 | 1,493 | 1,564 | +79 | +5.3% | 964,400 |
| 2023/04/10 | 1,480 | 1,537 | 1,470 | 1,485 | +6 | +0.4% | 592,700 |
| 2023/04/07 | 1,435 | 1,516 | 1,425 | 1,479 | +23 | +1.6% | 895,900 |
| 2023/04/06 | 1,476 | 1,533 | 1,447 | 1,456 | -39 | -2.6% | 715,800 |
501～
550
件表示中 / 3734件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 103,700円 | - | - | 0.00% | - | 6.84倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| レナサイエンス | 179,600円 | -14.4% | - | 0.00% | - | 13.27倍 |
|
東北大発創薬ベンチャー。創業者の宮田同大教授が発見した低分子化合物を使い治療薬を開発 |
| アンジェス | 6,200円 | +110.0% | - | 0.00% | - | 10.67倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| 扶桑薬 | 209,600円 | +1.6% | -12.7% | 4.29% | 7.78倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 30,400円 | - | - | 0.00% | - | 2.80倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム
